138 related articles for article (PubMed ID: 9456104)
1. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass.
Chiba Y; Morioka K; Muraoka R; Ihaya A; Kimura T; Uesaka T; Tsuda T; Matsuyama K
Ann Thorac Surg; 1998 Jan; 65(1):107-13; discussion 113-4. PubMed ID: 9456104
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass.
Morioka K; Muraoka R; Chiba Y; Ihaya A; Kimura T; Noguti H; Uesaka T
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):45-54. PubMed ID: 8551788
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
4. Concentrated platelets harvesting before cardiopulmonary bypass improved cardiac and pulmonary function.
Kunitomo R; Kitamura N; Utoh J; Nishimura K; Sakaguchi H; Uemura S; Hagiwara S
J Cardiovasc Surg (Torino); 2002 Apr; 43(2):161-5. PubMed ID: 11887048
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery.
Gu YJ; de Vries AJ; Boonstra PW; van Oeveren W
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):494-500. PubMed ID: 8751518
[TBL] [Abstract][Full Text] [Related]
6. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
7. The effects of using a leukocyte removal filter during cold blood cardioplegia.
Ichihara T; Yasuura K; Maseki T; Matsuura A; Miyahara K; Ito T; Kato S; Mizuno S; Tamaki S; Seki A
Surg Today; 1994; 24(11):966-72. PubMed ID: 7772907
[TBL] [Abstract][Full Text] [Related]
8. Influence of PMEA-coated bypass circuits on perioperative inflammatory response.
Ninomiya M; Miyaji K; Takamoto S
Ann Thorac Surg; 2003 Mar; 75(3):913-7; discussion 917-8. PubMed ID: 12645716
[TBL] [Abstract][Full Text] [Related]
9. Leucocyte depletion and prevention of reperfusion injury during cardiopulmonary bypass: a clinical study.
Chiba Y; Muraoka R; Ihaya A; Morioka K; Sasaki M; Uesaka T
Cardiovasc Surg; 1993 Aug; 1(4):350-6. PubMed ID: 8076058
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit.
Gu YJ; de Vries AJ; Vos P; Boonstra PW; van Oeveren W
Ann Thorac Surg; 1999 Mar; 67(3):604-9. PubMed ID: 10215195
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting.
Gu YJ; Mariani MA; van Oeveren W; Grandjean JG; Boonstra PW
Ann Thorac Surg; 1998 Feb; 65(2):420-4. PubMed ID: 9485239
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate.
Gu YJ; Obster R; Haan J; Gallandat Huet RC; Eijgelaar A; van Oeveren W
Artif Organs; 1993 Jul; 17(7):660-5. PubMed ID: 8338443
[TBL] [Abstract][Full Text] [Related]
15. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass.
Hachida M; Hanayama N; Okamura T; Akasawa T; Maeda T; Bonkohara Y; Endo M; Hashimoto A; Koyanagi H
ASAIO J; 1995; 41(3):M291-4. PubMed ID: 8573809
[TBL] [Abstract][Full Text] [Related]
16. Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study.
Dapper F; Neppl H; Wozniak G; Strube I; Zickmann B; Hehrlein FW; Neuhof H
Thorac Cardiovasc Surg; 1992 Dec; 40(6):345-51. PubMed ID: 1290181
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil depletion reduces myocardial reperfusion morbidity.
Palatianos GM; Balentine G; Papadakis EG; Triantafillou CD; Vassili MI; Lidoriki A; Dinopoulos A; Astras GM
Ann Thorac Surg; 2004 Mar; 77(3):956-61. PubMed ID: 14992906
[TBL] [Abstract][Full Text] [Related]
18. Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators.
Martin W; Carter R; Tweddel A; Belch J; el-Fiky M; McQuiston AM; McLaren M; Wheatley DJ
Eur J Cardiothorac Surg; 1996; 10(9):774-83. PubMed ID: 8905281
[TBL] [Abstract][Full Text] [Related]
19. Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B2 levels.
Kobinia GS; LaRaia PJ; D'Ambra MN; Fabri BM; Aylesworth CA; Peterson MB; Watkins WD; Buckley MJ
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):852-7. PubMed ID: 3754915
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
